Fayette J, Licitra L, Harrington K, Haddad R, et al. INTERLINK-1: A Phase III, Randomized, Placebo-Controlled Study of Monalizumab Plus Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 2025 Apr 29. doi: 10.1158/1078-0432.CCR-25-0073.
PMID: 40300079